ENDOTHELIAL CELL DYSFUNCTION & APOPOTOSIS IN ACCELERATED GRAFT ARTERIOSCLEROSIS
内皮细胞功能障碍
基本信息
- 批准号:6273138
- 负责人:
- 金额:$ 24.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-05-30 至 1999-04-30
- 项目状态:已结题
- 来源:
- 关键词:CD antigens apoptosis arteriosclerosis cell transplantation cellular pathology complement pathway coronary artery cytomegalovirus cytotoxic T lymphocyte electromyography free radicals guanine nucleotide binding protein heart transplantation immunocytochemistry laboratory mouse laboratory rat nuclear factor kappa beta oxidative stress phosphatidylserines receptor coupling transfection vascular endothelium
项目摘要
Accelerated graft arteriosclerOsis (AGA) represents a major obstacle to
long term survival of heart transplant recipients. While it has become
clear that AGA is a multifactorial problem, the specific mechanisms
leading to AGA remain unknown. Because of their pivotal role in the
maintenance of vessel homeostasis, endothelial cells (EcS) are likely to
represent prime targets in the pathogenesis of AGA. Project 1 is designed
to provide in-depth characterization of the process that affects ECs in
AGA, from extracellular factors to intracellular molecular pathways that
transduce messages to the genome of ECs. By integrating our studies on ECs
with other projects of this program, we intend to provide information that
will be key to the development of specific strategies to suppress AGA. In
AGA, the functional damage to the endothelium is diffuse.
Morphologically, areas of endothelial erosion can be found dispersed along
the coronary vessels. Several mechanisms of BC ii-jury have been
implicated in AGA: (i) oxidative injury resulting from
ischemia/reperfusion at the time of surgery; (ii) immunological injuries
involving complement activation, processing and presentation of antigens,
activation and adhesion of T.lymphocytes, in particular cytolytic T-
lymphocytes (CTL), sequestration of monocytes, production of antibodies
against allo- or iso-antigens, and dysregulation of the immune system with
Cyclosporine A; (iii) injury with CMV-infection/reactivation; and (iv)
direct Cyclosporine A toxicity. These various mechanisms could contribute
either independently or in concert, to the diffuse abnormalities of ECs in
AGA. Particular emphasis will be placed on the following pathway, which
will provide the basis for the specific aims of this project: (i) the
initial injury results in uncoupling of Gi-2 from its membrane receptors;
(ii) the uncoupling of Gi-2 then results in BC dysfunction and
overexpression of Fas on the surface of ECs, through a pathway that
requires NF-kappaB activation; (iii) overexpression of Fas, in turn,
results in the "kiss of death" as CTL bind to the ECs through the
interaction of Fas and Fas-ligand present on the CTL surface; (iv)
increased BC apoptosis will further aggravate the dysfunctional aspect of
the endothelium and promote fibrin production and deposition due to the
abnormal presence of phosphatidylserine on the surface of ECs. As a
result, the endothelium in these patients is not capable of carrying out
its usual functions namely, vasodilation, anti-thrombotic effect, anti-
proliferative effect for the cells of the vessel wall, control of the
attachment of inflammatory cells, and homeostasis of extracellular protein
production, leading to the development of AGA.
加速移植动脉硬化(AGA)代表了
心脏移植受者的长期生存。虽然它已经变成
清楚地表明,AGA是一个多因素问题,即特定机制
导致AGA仍然未知。由于它们在
维持血管稳态,内皮细胞(EC)可能
代表AGA发病机理中的主要靶标。项目1是设计的
为影响ECS的过程提供深入的表征
AGA,从细胞外因子到细胞内分子途径
将信息传递给ECS的基因组。通过整合我们对EC的研究
在该计划的其他项目中,我们打算提供信息
将是制定抑制AGA的特定策略的关键。在
AGA,对内皮的功能损害是分散的。
从形态上讲,可以发现内皮侵蚀的区域分散
冠状动脉。 BC II-JURY的几种机制已经
与AGA有关:(i)由
手术时的缺血/再灌注; (ii)免疫伤害
涉及抗原的补体激活,加工和表现,
T.淋巴细胞的激活和粘附,特别是细胞溶解的T-
淋巴细胞(CTL),单核细胞的隔离,抗体的产生
针对同种或异抗原,以及免疫系统的失调
环孢素A; (iii)CMV感染/重新激活的损伤; (iv)
直接环孢菌素A毒性。这些各种机制可能有助于
无论是独立还是共同,以EC的弥漫性异常
Aga。特别重点将放在以下途径上
将为该项目的具体目的提供基础:(i)
最初的损伤导致GI-2与膜受体的解偶联;
(ii)GI-2的解偶联,然后导致BC功能障碍和
通过EC表面的FAS过表达,通过一条途径
需要NF-kappab激活; (iii)FAS的过表达反过来
由于CTL通过
CTL表面上存在FAS和FAS配体的相互作用; (iv)
BC凋亡增加将进一步加剧
内皮并促进纤维蛋白的产生和沉积
EC表面上磷脂酰丝氨酸的异常存在。 作为
结果,这些患者的内皮无法进行
它通常的功能,即血管舒张,抗栓性效应,抗
血管壁细胞的增殖作用,控制
炎症细胞的附着和细胞外蛋白的稳态
生产,导致AGA的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NICHOLAS A FLAVAHAN其他文献
NICHOLAS A FLAVAHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NICHOLAS A FLAVAHAN', 18)}}的其他基金
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
内皮成熟受损和血管疾病的发育起源
- 批准号:
9279232 - 财政年份:2014
- 资助金额:
$ 24.59万 - 项目类别:
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
内皮成熟受损和血管疾病的发育起源
- 批准号:
8759467 - 财政年份:2014
- 资助金额:
$ 24.59万 - 项目类别:
Impaired Endothelial Maturation and the Developmental Origin of Vascular Disease
内皮成熟受损和血管疾病的发育起源
- 批准号:
9085330 - 财政年份:2014
- 资助金额:
$ 24.59万 - 项目类别:
Endothelial exocytosis and the vascular dysfunction of aging
内皮胞吐作用与衰老的血管功能障碍
- 批准号:
8059698 - 财政年份:2010
- 资助金额:
$ 24.59万 - 项目类别:
Endothelial exocytosis and the vascular dysfunction of aging
内皮胞吐作用与衰老的血管功能障碍
- 批准号:
7878227 - 财政年份:2010
- 资助金额:
$ 24.59万 - 项目类别:
Mechanisms of Vascular Dysfunction in Vibration Injury
振动损伤中血管功能障碍的机制
- 批准号:
7390919 - 财政年份:2006
- 资助金额:
$ 24.59万 - 项目类别:
Mechanisms of Vascular Dysfunction in Vibration Injury
振动损伤中血管功能障碍的机制
- 批准号:
7422526 - 财政年份:2006
- 资助金额:
$ 24.59万 - 项目类别:
Mechanisms of Vascular Dysfunction in Vibration Injury
振动损伤中血管功能障碍的机制
- 批准号:
7491610 - 财政年份:2005
- 资助金额:
$ 24.59万 - 项目类别:
Mechanisms of Vascular Dysfunction in Vibration Injury
振动损伤中血管功能障碍的机制
- 批准号:
7255586 - 财政年份:2005
- 资助金额:
$ 24.59万 - 项目类别:
alpha2C Adrenergic Receptors & Cutaneous Circulation
α2C 肾上腺素能受体
- 批准号:
6903241 - 财政年份:2005
- 资助金额:
$ 24.59万 - 项目类别:
相似国自然基金
选择性抑制免疫蛋白酶体在减轻移植物动脉内皮细胞凋亡防治移植物动脉硬化中的作用及机制研究
- 批准号:81870304
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
下调LncRNA-p21抑制p21及p53通路促进血管平滑肌细胞增殖与凋亡促进动脉粥样硬化进展
- 批准号:81800323
- 批准年份:2018
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
移植物动脉内皮细胞凋亡诱导受体动脉内皮间质转化参与移植物动脉硬化的作用及机制研究
- 批准号:81400674
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
TAK1介导细胞凋亡诱导血管平滑肌细胞表达SDF-1α促进移植物动脉硬化的作用机制
- 批准号:81370582
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
流感病毒感染作为“二次打击”通过UPR-CHOP途径和TLRs信号联合诱导巨噬细胞凋亡致动脉粥样硬化斑块不稳定
- 批准号:81241006
- 批准年份:2012
- 资助金额:10.0 万元
- 项目类别:专项基金项目
相似海外基金
ENDOTHELIAL CELL DYSFUNCTION & APOPOTOSIS IN ACCELERATED GRAFT ARTERIOSCLEROSIS
内皮细胞功能障碍
- 批准号:
6642364 - 财政年份:2001
- 资助金额:
$ 24.59万 - 项目类别:
ENDOTHELIAL CELL DYSFUNCTION & APOPOTOSIS IN ACCELERATED GRAFT ARTERIOSCLEROSIS
内皮细胞功能障碍
- 批准号:
6448216 - 财政年份:2001
- 资助金额:
$ 24.59万 - 项目类别:
ENDOTHELIAL CELL DYSFUNCTION & APOPOTOSIS IN ACCELERATED GRAFT ARTERIOSCLEROSIS
内皮细胞功能障碍
- 批准号:
6312808 - 财政年份:2000
- 资助金额:
$ 24.59万 - 项目类别:
ENDOTHELIAL CELL DYSFUNCTION & APOPOTOSIS IN ACCELERATED GRAFT ARTERIOSCLEROSIS
内皮细胞功能障碍
- 批准号:
6110627 - 财政年份:1999
- 资助金额:
$ 24.59万 - 项目类别:
ENDOTHELIAL CELL DYSFUNCTION & APOPOTOSIS IN ACCELERATED GRAFT ARTERIOSCLEROSIS
内皮细胞功能障碍
- 批准号:
6242621 - 财政年份:1997
- 资助金额:
$ 24.59万 - 项目类别: